Ping Li

8.2k total citations · 1 hit paper
286 papers, 5.5k citations indexed

About

Ping Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ping Li has authored 286 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Pulmonary and Respiratory Medicine, 111 papers in Oncology and 95 papers in Molecular Biology. Recurrent topics in Ping Li's work include Gastric Cancer Management and Outcomes (104 papers), Metastasis and carcinoma case studies (50 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (30 papers). Ping Li is often cited by papers focused on Gastric Cancer Management and Outcomes (104 papers), Metastasis and carcinoma case studies (50 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (30 papers). Ping Li collaborates with scholars based in China, United States and Italy. Ping Li's co-authors include Chang‐Ming Huang, Chao‐Hui Zheng, Jian‐Wei Xie, Jian‐Xian Lin, Qi‐Yue Chen, Long‐Long Cao, Mi Lin, Jia-Bin Wang, Ru‐Hong Tu and Jun Lü and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Ping Li

276 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials

2018 326 citations Ping Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ping Li China	36	2.1k	1.9k	1.9k	1.3k	1.1k	286	5.5k
Yasuhiko Mohri Japan	42	2.1k 1.0×	1.4k 0.7×	1.4k 0.7×	1.2k 0.9×	1.9k 1.8×	226	5.4k
Masahiko Koike Japan	40	2.1k 1.0×	1.9k 1.0×	1.7k 0.9×	830 0.6×	1.9k 1.8×	234	5.4k
Michelangelo Fiorentino Italy	47	2.0k 0.9×	2.8k 1.4×	2.2k 1.1×	1.6k 1.2×	1.4k 1.3×	303	6.8k
Seung Tae Kim South Korea	35	2.4k 1.2×	1.9k 1.0×	1.2k 0.6×	1.0k 0.8×	1.0k 1.0×	286	4.9k
Jing Gao China	36	1.9k 0.9×	1.4k 0.7×	1.7k 0.9×	1.1k 0.8×	673 0.6×	240	4.6k
Ferdinando De Vita Italy	43	3.4k 1.6×	2.2k 1.1×	2.0k 1.0×	1.0k 0.8×	1.2k 1.1×	207	6.0k
Michele Orditura Italy	44	3.4k 1.6×	2.1k 1.1×	1.9k 1.0×	1.0k 0.8×	1.2k 1.1×	181	6.1k
Mitsuro Kanda Japan	42	2.8k 1.3×	2.1k 1.1×	1.5k 0.8×	972 0.7×	2.2k 2.0×	274	5.8k
Yuhong Li China	38	2.3k 1.1×	1.6k 0.8×	1.9k 1.0×	1.9k 1.4×	1.2k 1.2×	212	5.6k
Chie Tanaka Japan	40	1.7k 0.8×	1.9k 1.0×	1.4k 0.7×	722 0.5×	1.6k 1.5×	264	4.6k

Countries citing papers authored by Ping Li

Since Specialization

Citations

This map shows the geographic impact of Ping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Li more than expected).

Fields of papers citing papers by Ping Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Li. The network helps show where Ping Li may publish in the future.

Co-authorship network of co-authors of Ping Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Li. A scholar is included among the top collaborators of Ping Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Li. Ping Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Guang‐Tan, Xiaowen Qiu, Chuan Liang Feng, et al.. (2025). Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy. Cancer Research. 85(11). 2117–2133. 2 indexed citations

Li, Ping, Kaixuan Wang, Jian Song, et al.. (2024). THBS1 knockdown suppresses pancreatic cancer progression through JAK2/STAT3 signaling pathway. Molecular and Cellular Probes. 79. 102003–102003.

Liu, Fei, Zhe Feng, Xueying Cao, et al.. (2024). Acute kidney injury in hospitalized patients with nonmalignant pleural effusions: a retrospective cohort study. BMC Nephrology. 25(1). 118–118.

Zhong, Qing, Junyu Chen, Zhiyu Liu, et al.. (2024). Long-term oncological outcomes of 3D versus 2D laparoscopic gastrectomy for gastric cancer: a randomized clinical trial. Gastric Cancer. 27(3). 598–610.

Li, Ping, et al.. (2024). DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma. Journal of Cancer. 15(8). 2276–2291. 2 indexed citations

Lin, Mi, Ru‐Hong Tu, Sheng-Ze Wu, et al.. (2024). Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway. Cell Death and Disease. 15(7). 497–497. 4 indexed citations

Wu, Chuanchen, Yuantao Mao, Fanghui Zhang, et al.. (2023). Uncovering the mechanism of cancer-associated fibroblasts induced immune evasion of hepatocellular carcinoma cells via in situ fluorescence imaging. Sensors and Actuators B Chemical. 389. 133891–133891. 8 indexed citations

Zhao, W. R., Xiaolan Li, Qian Wang, et al.. (2023). Molecular mechanism of miRNA regulating PD-L1 expression. Gene Reports. 31. 101763–101763. 1 indexed citations

Wu, Chao, Zhenxing Sun, Xin Yu, et al.. (2023). DKK1 Impairs the Tumor Response to αPD‐1 Immunotherapy by Inactivating CD8⁺ T Cells and Recruiting MDSC Cells in HNSC. Advanced Therapeutics. 6(12). 1 indexed citations

10.

Zhong, Qing, Qi‐Yue Chen, Mark J. Truty, et al.. (2023). A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large‐Sample Retrospective Study. World Journal of Surgery. 47(7). 1762–1771. 1 indexed citations

11.

Lin, Guang‐Tan, Zhiyu Liu, Jian‐Xian Lin, et al.. (2023). Comparison of the efficacy between immunochemotherapy and chemotherapy in gastric cancer accompanied with synchronous liver metastases: A real‐world retrospective study. Cancer Medicine. 12(11). 12221–12233. 1 indexed citations

12.

Lin, Jian‐Xian, Qiaoling Zheng, Yinghong Yang, et al.. (2022). m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer. Cell Death and Disease. 13(5). 463–463. 34 indexed citations

13.

Lin, Ju‐Li, Jian‐Xian Lin, Chao‐Hui Zheng, et al.. (2020). Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis. BMC Cancer. 20(1). 638–638. 21 indexed citations

14.

Lin, Jian‐Xian, Wei Wang, Jacopo Desiderio, et al.. (2019). Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data. BMC Cancer. 19(1). 1048–1048. 20 indexed citations

15.

Wang, Jia-Bin, Chao‐Hui Zheng, Ping Li, et al.. (2019). A modified subclassification to evaluate the survival of patients with N3 gastric cancer: an international database study. BMC Cancer. 19(1). 21–21. 2 indexed citations

16.

Lin, Jian‐Xian, Jian‐Wei Xie, Jia‐Bin Wang, et al.. (2019). Clinicopathological features and impact of adjuvant chemotherapy on the long‐term survival of patients with multiple gastric cancers: a propensity score matching analysis. Cancer Communications. 39(1). 4–4. 4 indexed citations

17.

Xie, Jian‐Wei, Ping Li, Jia-Bin Wang, et al.. (2018). Modified AJCC staging of gastric neuroendocrine carcinoma based on T staging can improve the capacity of prognosis assessment. Journal of Cancer Research and Clinical Oncology. 144(12). 2391–2397. 7 indexed citations

18.

Zhong, Qing, Qi‐Yue Chen, Jian‐Wei Xie, et al.. (2018). Incidence trend and conditional survival estimates of gastroenteropancreatic neuroendocrine tumors: A large population‐based study. Cancer Medicine. 7(7). 3521–3533. 20 indexed citations

19.

Lin, Jian‐Xian, Jun-Peng Lin, Ping Li, et al.. (2018). Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database. European Journal of Surgical Oncology. 44(8). 1205–1211. 8 indexed citations

20.

Lin, Jian-Xian, Ping Li, Jian-Wei Xie, et al.. (2018). Comprehensive Complication Index Predicts Cancer-Specific Survival of Patients with Postoperative Complications after Curative Resection of Gastric Cancer. Gastroenterology Research and Practice. 2018. 1–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact